Abstract We previously reported that mRNA expression of the unique alternatively spliced OPRM1 isoform μ-opioid receptor-1K (MOR-1K), which exhibits excitatory cellular signaling, is elevated in HIV-infected individuals with combined neurocognitive impairment (NCI) and HIV encephalitis (HIVE). It has recently been shown that the β 2 -adrenergic receptor (β 2 -AR) chaperones MOR-1K, normally localized intracellularly, to the cell surface. Here, we found mRNA expression of the adrenoceptor beta 2 (ADRB2) gene is also elevated in NCI-HIVE individuals, as well as that β 2 -AR protein expression is elevated in HIV-1-infected primary human astrocytes treated with morphine, and discuss the implications for MOR-1K subcellular localization in this condition.
Introduction
While numerous splice variants of the μ-opioid receptor (MOR) have been identified (reviewed in (Pan 2005) ), a 6-transmembrane isoform of MOR, termed MOR-1K, has also been discovered (Shabalina et al. 2009 ). The characterization of MOR-1K has revealed unique properties compared to the 7-transmembrane canonical MOR-1 such as excitatory cellular signaling with morphine stimulation and that the truncated receptor is mainly localized to intracellular compartments Gris et al. 2010) .
As excitatory cellular signaling by opiates such as morphine could be a mechanism underlying opiate-driven enhanced HIV-related neuropathogenesis (El-Hage et al. 2005; Gurwell et al. 2001; Hauser et al. 2012 ), we previously examined MOR-1K mRNA expression levels in brain tissue from groups of HIV-infected individuals with varying levels of neurocognitive impairment (NCI) ± HIV encephalitis (HIVE) (Dever et al. 2014 ), many of which had a history of polysubstance use including opiates (Dever et al. 2015 . We found MOR-1K mRNA was significantly elevated in the group of individuals that were most severely impaired with combined NCI-HIVE. Furthermore, in this same study, networking analysis revealed the product of the FLNA gene, filamin A, as a potential interacting protein with MOR in the NCI-HIVE condition, and we found FLNA mRNA expression levels were also significantly elevated in these individuals as well as that filamin A expression trafficked MOR-1K to the cell surface in vitro.
Although the consequences of MOR-1K cell surface localization were not known at the time our study was published, a recent report has shown expression of the β 2 -adrenergic receptor (β 2 -AR), but not β 1 -AR or β 3 -AR, also chaperones MOR-1K to the plasma membrane and that the MOR-1K/ β 2 -AR heterodimer mediates the excitatory cellular signaling effects of this MOR variant . The purpose of the current study was therefore to expand on the findings of Samoshkin et al. by examining expression of the β 1-3 -AR genes in the context of HIV infection. Elevated levels specifically of the β 2 -AR subtype may be another mechanism that could result in MOR-1K trafficking to the surface of cells in NCI-HIVE individuals and lead to enhanced neuropathogenesis in this condition from opiate exposure.
Materials and methods

Human brain tissue
Human brain tissue was obtained from a subset of samples used in the National NeuroAIDS Tissue Consortium (NNTC) Gene Array Project (Gelman et al. 2012; Morgello et al. 2001) . Briefly, individuals examined were either HIVnegative (n = 6) or HIV-positive with combined neurocognitive impairment (NCI) and HIV encephalitis (HIVE) (n = 5) with post-mortem tissue taken from the frontal lobe white matter and/or frontal cortex. Details on the individual samples analyzed for each group in this study have been described previously (Dever et al. 2014 (Dever et al. , 2015 .
qRT-PCR
Total RNA was isolated using the miRNeasy Mini Kit (Qiagen; Valencia, CA, USA) and used to generate cDNA templates by reverse transcription of 1 μg RNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems; Carlsbad, CA, USA) according to the manufacturer's instructions. PCR reactions were performed in a total volume of 20 μL containing SensiMix SYBR qPCR reagents (Bioline; Taunton, MA, USA) using a Corbett Rotor-Gene 6000 real-time PCR system (Qiagen). PCR conditions consisted of an initial hold step at 95°C for 10 min followed by 40 amplification cycles of 95°C for 10 s, 58°C for 30 s, and 72°C for 30 s. Sequences of the primer sets used were forward: 5′-CGGGAACAGGAACACACTAC-3′ and reverse: 5′-TTTGCCCTACACAAGGAAAG-3′ for ADRB1; forward: 5′-GAGCACAAAGCCCTCAAGAC-3′ and reverse: 5′-TGGAAGGCAATCCTGAAATC-3′ for ADRB2; forward: 5′-ACCATCCTCTTGCTCTCTGT-3′ and reverse: 5′-AGCCTGGAGAACACTAAGGT-3′ for ADRB3; and forward: 5′-GCTGCGGTAATCATGAGGATAAGA-3′ and reverse: 5′-TGAGCACAAGGCCTTCTAACCTTA-3′ for TATA-binding protein (TBP). The specificity of the amplified products was verified by melting curve analysis and agarose gel electrophoresis. qRT-PCR data were calculated as relative expression levels by normalization to TBP mRNA using the 2 −ΔΔCt method (Livak and Schmittgen 2001) .
HIV-1 infection and treatment of astrocytes
Primary human brain astrocytes were purchased from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultured according to the manufacturer's instructions. Cells grown to~75-80 % confluency were infected with the CCR5-tropic HIV-1 SF162 strain (obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: HIV-1 SF162 Virus from Dr. Jay Levy (Cheng-Mayer and Levy 1988)) at a concentration of 1 ng HIV-1 p24/10 6 cells and cultured for 7 days in the presence or absence of 1 μM morphine sulfate (Sigma-Aldrich; St. Louis, MO, USA).
Western blotting
Whole cell lysates were prepared in RIPA buffer supplemented with a mixture of protease and phosphatase inhibitors and separated by SDS-PAGE for immunoblotting. Primary antibodies used were β 2 -AR (R11E1) at a 1:100 dilution and β-actin (C4) at a 1:200 dilution, both from Santa Cruz Biotechnology (Dallas, TX, USA). The addition of each primary antibody was followed by incubation with a secondary antibody conjugated to horseradish peroxidase (Cell Signaling Technology; Danvers, MA, USA) used at a 1:1000 dilution. Immunoblots were exposed to SuperSignal West Femto Substrate (Thermo Scientific; Waltham, MA, USA) and visualized using a ChemiDoc imaging system (Bio-Rad Laboratories; Hercules, CA, USA). Protein band intensity was quantified with ImageJ software (National Institutes of Health (NIH); Bethesda, MD, USA).
Statistics
Student's unpaired, two-tailed t tests for paired data and oneway analysis of variance (ANOVA) followed by StudentNewman-Keuls post hoc test for multiple comparisons were performed using GraphPad Prism 5 (GraphPad Software; La Jolla, CA, USA). A value of p < 0.05 was considered significant.
Results mRNA expression of β-AR genes in NCI-HIVE individuals
To determine whether the expression of β-AR genes might differ in a manner where corresponding protein increases could affect MOR-1K subcellular localization in the context of HIV infection, mRNA expression levels of the adrenoceptor beta (ADRB) genes ADRB1, ADRB2, and ADRB3 were examined between uninfected and HIVinfected individuals with combined NCI-HIVE using qRT-PCR. NCI-HIVE individuals were chosen for this analysis as we previously showed that expression of MOR-1K mRNA was significantly elevated in this condition compared to other groups of HIV-infected individuals with varying levels of NCI (Dever et al. 2014) . Interestingly, out of ADRB1, ADRB2, and ADRB3 expression, only ADRB2 mRNA was found to be significantly elevated in NCI-HIVE compared to uninfected individuals (Fig. 1) .
-AR protein expression in astrocytes following HIV-1 infection and morphine treatment
We previously profiled for the presence of MOR-1K mRNA across various primary human central nervous system cell types and detected expression in astrocytes, but not microglia and neurons (Dever et al. 2014) . To determine whether HIVopiate drug interactions might affect MOR-1K subcellular localization in astrocytes, β 2 -AR protein expression levels were examined by western blotting analysis in this cell type after HIV-1 infection ± morphine treatment. Although β 2 -AR protein expression was significantly higher with HIV-1 infection compared to morphine treatment alone, the combined effect resulted in significantly elevated expression levels compared to all other groups of cells (Fig. 2) .
Discussion
While the functional activity of MOR-1K may have been previously questioned due to its intracellular localization, it is now clear that this receptor can translocate to the cell surface by interactions with at least two different proteins, filamin A and β 2 -AR (Dever et al. 2014; Samoshkin et al. 2015) . However, it appears that the heterodimerization of MOR-1K specifically with β 2 -AR, but not β 1 -AR or β 3 -AR, is the primary interaction responsible for mediating the excitatory cellular signaling effects this MOR variant exhibits upon opiate stimulation . The complementary data presented in this study showing ADRB2, but not ADRB1 or ADRB3, mRNA expression levels are significantly elevated in NCI-HIVE individuals, along with simultaneous significant elevations in MOR-1K mRNA (Dever et al. 2014) , suggests that in this condition corresponding β 2 -AR/MOR-1K protein increases could maximize trafficking of MOR-1K to the surface of cells in a manner which promotes its excitatory signaling activity in the presence of opiates. Therefore, our findings present a potential mechanism by which opiate exposure in NCI-HIVE individuals may trigger cellular signaling events that could lead to enhanced neuropathogenesis from HIVopiate drug interactions (reviewed in ). Furthermore, our results showing elevated levels of β 2 -AR protein expression in HIV-1-infected astrocytes with combined morphine treatment point to a cell type where these interactions Fig. 1 ADRB2, but not ADRB1 or ADRB3, mRNA expression levels are elevated in HIV-infected individuals with combined neurocognitive impairment (NCI) and HIV encephalitis (HIVE). Expression of the indicated genes was measured by qRT-PCR for the indicated groups of individuals. Data are presented relative to HIV-negative individuals which were set to a value of 1. p = 0.1295 for ADRB1, p = 0.0264 for ADRB2, and p = 0.1298 for ADRB3 when HIV-negative and HIV-positive/NCI-HIVE groups were compared. *p < 0.05. Error bars show the SEM Fig. 2 β 2 -AR protein expression levels are elevated in HIV-1-infected primary human astrocytes with combined morphine treatment. Expression of β 2 -AR was detected by western blotting analysis for the indicated groups of cells. β-Actin was used as a normalization control. Data are presented relative to control cells which were set to a value of 1. F(3,4) = 22.53, p = 0.0057. # p < 0.05 when compared to morphine treatment and *p < 0.05 when compared to all other groups. Error bars show the SEM for two independent experiments. Representative blots are shown via this mechanism may be of particular importance. As we were unable to perform other assays with human brain tissue due to the limited amounts available, future studies will be needed to confirm our findings with mRNA expression at the protein level by western blotting and immunohistochemical analyses, preferably using samples from uninfected and NCI-HIVE individuals with clear histories of opiate use/non-use.
Apart from β 2 -AR, the function of cell surface-localized MOR-1K in cellular signaling and non-canonical processes involving MOR such as HIV cellular binding and entry with chemokine receptors is an area needing future investigation. For example, MOR can form heterodimers and undergo crossdesensitization with the chemokine HIV co-receptor CCR5 ), and we previously showed that the action of the CCR5-mediated viral entry inhibitor maraviroc was attenuated by morphine in a MOR-dependent manner (ElHage et al. 2013) . Therefore, given that the subcellular localization of MOR-1K appears not to be constitutive but mediated by the expression of interacting proteins, this isoform could uniquely affect cellular signaling and viral entry processes in a regulated manner compared to other MOR variants.
In conclusion, our past and present findings suggest that in NCI-HIVE individuals, elevated levels of mRNAs encoding proteins known to interact with MOR-1K could lead to localization of this receptor on the surface of cells by multiple protein-protein interactions. In addition, as β 2 -AR can chaperone other G-protein-coupled receptors such as the CB1 cannabinoid and M71 olfactory receptors (Hague et al. 2004; Hudson et al. 2010) , the results presented here have broader implications in that the cell surface complement of receptors may be dramatically altered in NCI-HIVE individuals which could negatively impact this condition in response to certain stimuli.
